Pulmonary fibrosis (PF) progression may be involved with arginine (Arg) metabolism and
immune balance. The present study aimed to explore the effects of L-Arginine (L-Arg) and L …

Pulmonary fibrosis is a chronic and progressively deteriorating lung condition that can be
replicated in laboratory animals by administering bleomycin, a chemotherapeutic antibiotic …

Background Pulmonary fibrosis is a multifaceted disease with high mortality and morbidity,
and it is commonly nonresponsive to conventional therapy. Purpose We explore the …

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease
without beneficial therapy, except for lung transplantation. A high oral dose of N …

The objective of this study was to evaluate the effectiveness of erythromycin (EM) on
bleomycin‐induced pulmonary fibrosis in rats and its possible mechanisms. Seventy‐five …

Background: The present study was undertaken to evaluate whether stimulation or inhibition
of nitric oxide (NO) synthesis could affect lung toxicity induced by chronic administration of …

Background Obstructive sleep apnea (OSA) is associated with pulmonary fibrosis. Chronic
intermittent hypoxia (CIH) is considered to be a surrogate of OSA. However, its exact role in …

Pulmonary fibrosis (PF) leads to chronic inflammation and accumulation of macrophages,
neutrophils, and lymphocytes in the alveoli. The factors involved in the development of PF …

Pulmonary fibrosis (PF) is a special type of pulmonary parenchymal disease, with chronic,
progressive, fibrosis, and high mortality. There is a lack of safe, effective, and affordable …

Pirfenidone (PFD), one acceptable medication for treating idiopathic pulmonary fibrosis
(IPF), is not well tolerated by patients at full doses. Hence, employing of some approaches …